Who
Michael John Sumner
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Inovio Pharmaceuticals.
In numbers
- Trades disclosed
- 61
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 Jun 2022
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —9,450 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $3,3122,693 at $1.23 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,450 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,450 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,876 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,684 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —46,876 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,684 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —9,450 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $3,3122,693 at $1.23 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,385 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $884680 at $1.30 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,385 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,385 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,385 | filing |
| 15 May 2026filed 18 May 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $884680 at $1.30 | filing |
| 31 Mar 2026filed 1 Apr 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —4,292 | filing |
| 31 Mar 2026filed 1 Apr 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,1281,223 at $1.74 | filing |
| 31 Mar 2026filed 1 Apr 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,292 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —4,292 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.